Verity Pharma

Privately held: no public share price · Canada

Assets

(1 total)
1Total Assets
1Approved
0Phase 3 / Filed
0Phase 1–2 / Early
1Diseases
Showing 1 of 1 assets
Target & Modality
Approved
Androgen receptor (AR)Small molecule
Male Hypogonadism
Hypogonadism

Upcoming events

No upcoming trial completions or earnings dates on record for this company's assets.

Regulatory and conference events

(1)

Filings, regulator decisions, scientific presentations, topline results and licensing deals, each from a dated source. When a source gives only the month, the month is shown.

Recent

October 2026Approvaltestosterone undecanoateHealth Canada approves TLANDO
CA, Health Canada · Lipocine Inc. · Source ↗

Financial reports

No financial reports recorded.